PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025

Type / Class
Equity / Common Shares, without par value
Symbol
PBM on Nasdaq
Shares outstanding
4,527,832
Price per share
$0.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-275,000
Value change
-$462,000
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Psyence Group Inc. 15% $380,084 678,722 Psyence Group Inc. 25 Mar 2025
Hudson Bay Capital Management LP 5% -50% $133,150 -$79,650 237,768 -37% Hudson Bay Capital Management LP 31 Mar 2025
AdvisorShares Trust 0.79% $15,077 26,924 AdvisorShares Trust 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM). This represents 0% of the company’s total 4,527,832 outstanding shares.

Institutional Holders of PSYENCE BIOMEDICAL LTD. - Common Shares, without par value (PBM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$462,000 $0.44 0
2025 Q2 275,000 $462,000 +$189,166 $1.68 1
2025 Q1 455,006 $272,834 -$1,162,584 $0.60 8
2024 Q4 749,870 $1,532,176 +$1,147,474 $2.11 11